P

Inventor

CORTI DAVIDE

CH54 patents
⚠️ This page may combine multiple inventors who share the name “CORTI DAVIDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HUMABS BIOMED SA

18 patents
US11390664B2Jul 19, 2022

Antibodies that potently neutralize hepatitis B virus and uses thereof

HUMABS BIOMED SA5 citations84
US10683344B2Jun 16, 2020

Antibodies that potently neutralize hepatitis B virus and uses thereof

HUMABS BIOMED SA6 citations84
US10047145B2Aug 14, 2018

Antibodies that potently neutralize RSV and uses thereof

HUMABS BIOMED SA5 citations84
US11117954B2Sep 14, 2021

Antibodies specifically binding to zika virus epitopes and uses thereof

HUMABS BIOMED SA2 citations73
US10759847B2Sep 1, 2020

Antibodies that potently neutralize RSV and uses thereof

HUMABS BIOMED SA1 citations73
US10329342B2Jun 25, 2019

Antibodies that potently neutralize RSV and uses thereof

HUMABS BIOMED SA3 citations73
US10072071B2Sep 11, 2018

Antibodies that neutralize RSV, MPV and PVM and uses thereof

HUMABS BIOMED SA2 citations73
US12304946B2May 20, 2025

Antibodies that neutralize hepatitis B virus and uses thereof

HUMABS BIOMED SA1 citations64
US9498531B2Nov 22, 2016

Antibodies that neutralize RSV, MPV and PVM and uses thereof

HUMABS BIOMED SA2 citations63
US12037381B2Jul 16, 2024

Antibodies that potently neutralize hepatitis B virus and uses thereof

HUMABS BIOMED SA0 citations62
US11912757B2Feb 27, 2024

Antibodies specifically binding to Zika virus epitopes and uses thereof

HUMABS BIOMED SA0 citations62
US11421020B2Aug 23, 2022

Antibodies that neutralize RSV, MPV and PVM and uses thereof

HUMABS BIOMED SA0 citations62
US11370829B2Jun 28, 2022

Antibodies that potently neutralize RSV and uses thereof

HUMABS BIOMED SA0 citations62
US11730813B2Aug 22, 2023

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

HUMABS BIOMED SA0 citations57
US11723977B2Aug 15, 2023

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

HUMABS BIOMED SA0 citations57
US11926658B2Mar 12, 2024

Multispecific antibodies specifically binding to Zika virus epitopes

HUMABS BIOMED SA0 citations52
US12297258B2May 13, 2025

Antibodies against Campylobacter species

HUMABS BIOMED SA0 citations50
US10703801B2Jul 7, 2020

Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof

HUMABS BIOMED SA0 citations47

MEDIMMUNE LLC

17 patents
US11174304B2Nov 16, 2021

Neutralizing anti-influenza B antibodies and uses thereof

MEDIMMUNE LLC5 citations83
US10519221B2Dec 31, 2019

Neutralizing anti-influenza B antibodies and uses thereof

MEDIMMUNE LLC8 citations83
US10294292B2May 21, 2019

Neutralizing anti-influenza B antibodies and uses thereof

MEDIMMUNE LLC4 citations83
US10494419B2Dec 3, 2019

Neutralizing anti-influenza A antibodies and uses thereof

MEDIMMUNE LLC9 citations82
US11787853B2Oct 17, 2023

Neutralizing anti-influenza b antibodies and uses thereof

MEDIMMUNE LLC2 citations72
US11059884B2Jul 13, 2021

Antibodies directed against Staphylococcus aureus leukotoxins

MEDIMMUNE LLC4 citations71
US11155606B2Oct 26, 2021

Antibody directed against S. aureus clumping factor a (ClfA)

MEDIMMUNE LLC3 citations69
US11117956B2Sep 14, 2021

Anti-O1 antibodies and uses thereof

MEDIMMUNE LLC3 citations69
US12325740B2Jun 10, 2025

Neutralizing anti-influenza B antibodies and uses thereof

MEDIMMUNE LLC0 citations61
US12492240B2Dec 9, 2025

Neutralizing anti-influenza A antibodies and uses thereof

MEDIMMUNE LLC0 citations60
US11932682B2Mar 19, 2024

Neutralizing anti-influenza A antibodies and uses thereof

MEDIMMUNE LLC0 citations60
US11578119B2Feb 14, 2023

Antibodies directed against Staphylococcus aureus leukotoxins

MEDIMMUNE LLC1 citations60
US11186627B2Nov 30, 2021

Neutralizing anti-influenza A antibodies and uses thereof

MEDIMMUNE LLC0 citations60
US12312397B2May 27, 2025

Anti-O2 antibodies and uses thereof

MEDIMMUNE LLC0 citations59
US12018068B2Jun 25, 2024

Anti-O1 antibodies and uses thereof

MEDIMMUNE LLC0 citations59
US11447542B2Sep 20, 2022

Anti-O2 antibodies and uses thereof

MEDIMMUNE LLC1 citations59
US11970527B2Apr 30, 2024

Antibody directed against S. aureus clumping factor A (ClfA)

MEDIMMUNE LLC0 citations58

US HEALTH

7 patents

VIR BIOTECHNOLOGY INC

3 patents

INST RES BIOMEDICINE

3 patents

ABB TECHNOLOGY AG

1 patent

BONFANTI ALESSANDRO

1 patent

Showing the top 50 of 54 patents by PatentIndex Score.